Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from WAVE

D-Wave Keeps Delivering Good News—So Why Is It Falling?

D-Wave Quantum's lackluster share price performance this year doesn't seem to match its strong growth and promising tech, but what must happen to change that?

MarketBeat

Does IonQ's Standout Earnings Give It an Advantage Over D-Wave?

Two of the potential leaders in the quantum space—D-Wave and IonQ—recently reported earnings; does either emerge as a clear favorite for investors in 2026?

MarketBeat

Despite a Double Miss, D-Wave's Earnings Could Fuel a New Rally

D-Wave confirmed that its growth trajectory remains impressive on multiple fronts, but it did come up short on top- and bottom-line figures for Q4 2025.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Ranking the 2026 NWSL Kits: Which Jerseys Rise to the Top

The league’s 16 clubs have revealed their uniforms for the upcoming season, with each team debuting at least one new kit.

Sports Illustrated

D-Wave CEO shrugs off short attacks with ‘revolutionary’ $550 million quantum computing acquisition

Less than 10% of D-Wave's clients are government research contracts, Alan Baratz says, proof it is offering commercially viable services.

Fortune

Is This Quantum Outperformer a New Threat to D-Wave?

Quantum Computing may seem like a standout because it has fallen less than its quantum rivals, but QUBT comes with some significant warning signs.

MarketBeat

Why Wedbush Thinks Norway Could Be Key for This Quantum Computing Stock -- and the Entire Industry

Norway's sovereign wealth fund invested $200 million in IonQ, $39 million in Rigetti, and $4 million in D-Wave. Wedbush sees this as a potential turning point for institutional investment in quantum computing stocks.

Barchart

Read news from The Economist, FT, and more,
with one subscription

What to Make of D-Wave's Latest Defense Industry Push

D-Wave is once again making efforts to expand into the defense space with a promising partnership with Davidson and Anduril, but can it yield new sales?

MarketBeat

Leatherman’s latest multitool is a subtle evolution of a classic

The updated model builds on the Wave+ formula with MagnaCut steel and design upgrades

D-Wave’s Big Deal, Bigger Question: Can Sales Catch Up to the Hype?

D-Wave's big acquisition in January may have some investors worried about the company's ability to manage costs. Could a boost in sales be on the way to help?

MarketBeat

D-Wave Files $330 Million Shelf: Growth Fuel or Dilution Risk?

D-Wave's acquisition of Quantum Circuits could solidify its technological dominance in the quantum computing space, but funding continued growth is tricky.

MarketBeat

3 Key Ways D-Wave Is Developing an Advantage in Quantum Computing

D-Wave's recent acquisition announcement and a major technological breakthrough with implications for scalability help to set it apart amid setbacks for rivals.

MarketBeat

How is cyberviolence against women and girls spreading across Europe?

A new report shows that cyberstalking, spyware, hate speech, and threats are among the most denounced cases of violence against women and girls in Europe.

Euronews

Inside D-Wave’s Major Acquisition—What Changes for Investors

D-Wave's planned $550-million purchase of Quantum Circuits will give it a big leg up technologically. But the company still faces commercialization questions.

MarketBeat

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

D-Wave Just Got a ‘Formidable’ Quantum Computing ‘Ally.’ Should You Buy QBTS Stock Here?

Is QBTS seen as a high-risk, high-reward bet as an early quantum leader or a core holding for conservative portfolios?

MarketBeat

D-Wave’s Year in Review: 2025 Wins Set the Stage for 2026

D-Wave had a successful year in 2025, marked by growing revenue, major sales, new technological advances, and more. This bodes well for 2026, but risks remain.

Barchart

A $550 Million Reason to Buy This Quantum Computing Stock Now

QBTS stock is back in focus on news of a transformational acquisition that strengthens its technology moat.

MarketBeat

D-Wave vs. IonQ vs. IBM vs. Google: Which Quantum Bets Will Win 2026?

Pure-play quantum companies may be attractive for their massive rallies in recent quarters, but some investors may find legacy tech names are a better fit.

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Dear D-Wave Quantum Computing Fans, Mark Your Calendars for January 7

D-Wave stock soared Monday after management announced plans of participating in the CES 2026. Jefferies sees QBTS shares hitting $45 in the coming year.

MarketBeat

Why 2026 Could Be the Year D-Wave Breaks Out

Despite more than tripling in value in the last year, D-Wave Quantum could continue its upward path into 2026. Is now the time to load up on shares?

Barchart

1 Analyst Is Betting on 73% Upside Potential for D-Wave Quantum Stock. Should You Buy QBTS Shares Here?

Jefferies just set a $45 price target on QBTS.

MarketBeat

4 Quantum Stocks to Watch as the Next Computing Revolution Unfolds

After the quantum computing industry faced some fall turbulence, investors might be looking to narrow exposure. These are some of the top firms to consider.

MarketBeat

The Quantum Fleet: Investing in the New Quantum Standard

New standards allow investors to properly value the diverse fleet of distinct hardware vehicles driving the commercialization of the quantum economy.

Benzinga

Nvidia, AMD, Wave Life Sciences, Toll Brothers And Carvana: Why These 5 Stocks Are On Investors' Radars Today

Major U.S. indexes closed lower on Monday, with the Dow slipping 0.45% to 47,739.32, the SP 500 easing 0.35% to 6,846.51, and the Nasdaq edging down 0.1% to 23,545.90.

Benzinga

Wave Life Sciences One-Shot Obesity Drug Slashes Dangerous Visceral Fat

Wave Life Sciences Ltd. (NASDAQ:WVE) on Monday shared interim data from the lowest therapeutic cohort of the ongoing first-in-human INLIGHT trial evaluating WVE-007, an investigational INHBE GalNAc-siRNA using Wave’s proprietary SpiNA design, for obesity.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.